Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

7 study records (showing up to 30 per record type)

• Registered trial NCT03990272 Phase 3 Completed (results not assessed here)
  Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
  Condition or outcome area: Allergic Rhinitis
  2017-03-20 · Subject: Qing Hao; 青蒿; Sweet Wormwood Herb; Herba Artemisiae Annuae;Artemisiae Annuae Herba · open the herb record · ClinicalTrials.gov
• Registered trial NCT03990272 Phase 3 Completed (results not assessed here)
  Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
  Condition or outcome area: Allergic Rhinitis
  2017-03-20 · Subject: Huang Hua Hao; 黄花蒿; Sweet Wormwood Equivalent Plant: Artemisia Apiacea; Artemisia Annua · open the herb record · ClinicalTrials.gov
• Registered trial NCT03366922 Completed (results not assessed here)
  Evaluation of Artemisia Annua and Moringa
  Condition or outcome area: HIV Infections
  2017-12-10 · Subject: Qing Hao; 青蒿; Sweet Wormwood Herb; Herba Artemisiae Annuae;Artemisiae Annuae Herba · open the herb record · ClinicalTrials.gov
• Registered trial NCT03366922 Completed (results not assessed here)
  Evaluation of Artemisia Annua and Moringa
  Condition or outcome area: HIV Infections
  2017-12-10 · Subject: Huang Hua Hao; 黄花蒿; Sweet Wormwood Equivalent Plant: Artemisia Apiacea; Artemisia Annua · open the herb record · ClinicalTrials.gov
• Systematic review registration CRD42022338850 Registered protocol, no results here: Review Ongoing
  Efficacy and safety of Artemisia Annua sublingual immunotherapy in seasonal allergic rhinitis: a systematic review and meta-analysis of randomised controlled trials
  Condition or outcome area: The prevalence of AR has increased year by year, imposing a significant burden on socio-economics. Recently, Artemisia annua Allergen Sublingual Immunotherapy Drops have been available in the Chinese market and they have been tested and found to be effective and safe in the treatment of patients with SAR with or without allergic conjunctivitis in a series of RCTS conducted by Luo Zhang (2017) ’s team. In the research, we aim to evaluate the efficacy and safety of Artemisia allergen sublingual im
  2022-06-21 · Subject: Huang Hua Hao; 黄花蒿; Sweet Wormwood Equivalent Plant: Artemisia Apiacea; Artemisia Annua · open the herb record
• Publication PMID 35934190 Research model: Cell Experiment
  Artemisia extracts differ from artemisinin effects on human hepatic CYP450s 2B6 and 3A4 in vitro
  Condition or outcome area: malaria; infectious diseases
  J Ethnopharmacol · 2022 · Subject: Huang Hua Hao; 黄花蒿; Sweet Wormwood Equivalent Plant: Artemisia Apiacea; Artemisia Annua · open the herb record · DOI 10.1016/j.jep.2022.115587
• Publication PMID 35245629 Research model: Animal Experiment
  Artemisia annua water extract attenuates DNCB-induced atopic dermatitis by restraining Th2 cell mediated inflammatory responses in BALB/c mice
  Condition or outcome area: atopic dermatitis; ear edema; malaria; skin dermatitis; eczema; tumor; dermatomycosis; jaundice
  J Ethnopharmacol · 2022 · Subject: Huang Hua Hao; 黄花蒿; Sweet Wormwood Equivalent Plant: Artemisia Apiacea; Artemisia Annua · open the herb record · DOI 10.1016/j.jep.2022.115160